PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180816 142059
20180813 174628
20170730 161346
DJI 0020
20180814 184212
20180202 160137
  • Regenerative Medicine Advanced Therapy Designation
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-11-05 By FDA
  • onlineotcmeds.com - 717697 - 10/15/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Condition-Specific Meeting Reports and Other Information Related to Patients' Experience
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Prescription Drug User Fee Amendments
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 15, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-04
  • Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-11-04 By FDA
  • Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-04
  • Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-04
  • Vaccines and Related Biological Products Advisory Committee October 9, 2025 Meeting Announcement - 10/09/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-11-04 By FDA
  • Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 7, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-04
  • Scientific Protein Laboratories, LLC - 712578 - 10/10/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Apotex Inc. - 714137 - 10/31/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
  • Kath Khemicals LLC - 711699 - 09/22/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-04 By FDA
Предыдущие записи
Тема: Scaffold от Danny Cooper.